PAVmed (PAVM) Gross Profit (2021 - 2025)
PAVmed's quarterly Gross Profit came in at -$703000.0 in Q4 2025, down 384.83% year-on-year from $246816.0 in Q4 2024, and down 1306.0% quarter-over-quarter from -$50000.0 in Q3 2025.
PAVmed has reported Gross Profit for 5 years, with the latest figure at -$703000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gross Profit fell 384.83% year-over-year to -$703000.0; the trailing twelve-month figure through Dec 2025 stood at -$1.0 million (up 93.52% YoY), and the FY2025 full-year result was -$817000.0, up 90.54% from the prior year.
- Gross Profit for Q4 2025 stood at -$703000.0, down from -$50000.0 in the prior quarter.
- The five-year high for Gross Profit was $56000.0 in Q3 2021, with the low at -$11.7 million in Q4 2023.
- Average Gross Profit over 5 years is -$2.1 million, with a median of -$695000.0 recorded in 2024.
- Year-over-year, Gross Profit tumbled 8421.43% in 2022 and surged 98.76% in 2024.
- Tracing PAVM's Gross Profit over 5 years: stood at -$141000.0 in 2021, then sank by 3904.96% to -$5.6 million in 2022, then tumbled by 107.63% to -$11.7 million in 2023, then surged by 98.76% to -$145000.0 in 2024, then plunged by 384.83% to -$703000.0 in 2025.
- The last three Gross Profit figures came in at -$703000.0 (Q4 2025), -$50000.0 (Q3 2025), and -$35000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -703,000.00 |
| Dec 31, 2025 | -703,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | -35,000.00 |
| Jun 30, 2025 | -35,000.00 |
| Mar 31, 2025 | -239,000.00 |
| Mar 31, 2025 | -239,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Jun 30, 2024 | -687,000.00 |
| Jun 30, 2024 | -687,000.00 |
| Mar 31, 2024 | -3.30 Mn |
| Mar 31, 2024 | -3.30 Mn |
| Dec 31, 2023 | -11.73 Mn |
| Dec 31, 2023 | -11.73 Mn |
| Sep 30, 2023 | -988,000.00 |
| Sep 30, 2023 | -988,000.00 |
| Jun 30, 2023 | -4.17 Mn |
| Jun 30, 2023 | -4.17 Mn |
| Mar 31, 2023 | -900,000.00 |
| Mar 31, 2023 | -900,000.00 |
| Dec 31, 2022 | -5.65 Mn |
| Dec 31, 2022 | -5.65 Mn |
| Sep 30, 2022 | -4.66 Mn |
| Sep 30, 2022 | -4.66 Mn |
| Mar 31, 2022 | -180,000.00 |
| Mar 31, 2022 | -180,000.00 |
| Dec 31, 2021 | -141,000.00 |
| Dec 31, 2021 | -141,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Sep 30, 2021 | 56,000.00 |